脂肪性-话题@MedSci

#脂肪性#

235篇内容 | 4211人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1810120, encodeId=8f121810120f3, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Intercept公司的奥贝胆酸即将成为第一个获批的非酒精性脂肪性肝炎（NASH）药物, objectType=article, longId=160664, objectId=b09616066462, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b09616066462, replyNumber=0, likeNumber=81, createdTime=2019-11-23, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b09616066462, moduleTitle=Intercept公司的奥贝胆酸即将成为第一个获批的非酒精性脂肪性肝炎（NASH）药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b09616066462)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810109, encodeId=1020181010970, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Hepatology：维生素E能改善非酒精性脂肪性肝炎和晚期肝硬化患者的免移植生存率和失代偿发生率, objectType=article, longId=157044, objectId=e66515e04472, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e66515e04472, replyNumber=0, likeNumber=0, createdTime=2019-06-04, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e66515e04472, moduleTitle=Hepatology：维生素E能改善非酒精性脂肪性肝炎和晚期肝硬化患者的免移植生存率和失代偿发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e66515e04472)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810142, encodeId=d0291810142db, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Clinica Chimica Acta：非酒精性脂肪性肝炎患者血清脂蛋白中缩醛磷脂的组成及其对氧化作用的敏感性, objectType=article, longId=177031, objectId=14cb1e703109, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14cb1e703109, replyNumber=0, likeNumber=51, createdTime=2019-09-11, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14cb1e703109, moduleTitle=Clinica Chimica Acta：非酒精性脂肪性肝炎患者血清脂蛋白中缩醛磷脂的组成及其对氧化作用的敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14cb1e703109)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810125, encodeId=d2181810125dc, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=AJG：吸烟与非酒精性脂肪性肝病发生风险之间的关系, objectType=article, longId=162839, objectId=a54816283974, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a54816283974, replyNumber=0, likeNumber=160, createdTime=2020-03-08, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a54816283974, moduleTitle=AJG：吸烟与非酒精性脂肪性肝病发生风险之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a54816283974)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810144, encodeId=6e3b18101444b, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Terns宣布其血管粘附蛋白-1抑制剂TERN-201治疗非酒精性脂肪性肝炎的I期临床中期阳性结果, objectType=article, longId=177617, objectId=12b31e761746, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12b31e761746, replyNumber=0, likeNumber=70, createdTime=2020-07-11, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12b31e761746, moduleTitle=Terns宣布其血管粘附蛋白-1抑制剂TERN-201治疗非酒精性脂肪性肝炎的I期临床中期阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12b31e761746)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810113, encodeId=f42e181011382, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Hepatology：丁酸钠可以通过上调肝脏GLP-1R表达减少高脂饮食诱导的非酒精性脂肪性肝炎, objectType=article, longId=158523, objectId=8bfb158523b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bfb158523b9, replyNumber=0, likeNumber=69, createdTime=2019-02-23, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bfb158523b9, moduleTitle=Hepatology：丁酸钠可以通过上调肝脏GLP-1R表达减少高脂饮食诱导的非酒精性脂肪性肝炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bfb158523b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810132, encodeId=2c1c1810132cd, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Clin Trans Gastroenterology：血清可溶性受体AGE（sRAGE）水平与不健康的生活方式和非酒精性脂肪性肝病相关, objectType=article, longId=172261, objectId=44c01e226150, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44c01e226150, replyNumber=0, likeNumber=86, createdTime=2020-04-15, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44c01e226150, moduleTitle=Clin Trans Gastroenterology：血清可溶性受体AGE（sRAGE）水平与不健康的生活方式和非酒精性脂肪性肝病相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44c01e226150)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810101, encodeId=fd3518101019f, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Gastroenterology：Simtuzumab对非酒精性脂肪性肝炎引起的桥接纤维化或代偿性肝硬化治疗无效, objectType=article, longId=151110, objectId=e6d0151110ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6d0151110ee, replyNumber=0, likeNumber=95, createdTime=2019-09-04, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6d0151110ee, moduleTitle=Gastroenterology：Simtuzumab对非酒精性脂肪性肝炎引起的桥接纤维化或代偿性肝硬化治疗无效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6d0151110ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810112, encodeId=a144181011271, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=《2018年国际肝移植协会意见：非酒精性脂肪性肝炎的管理和治疗》摘译, objectType=article, longId=158513, objectId=a0f9158513f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0f9158513f6, replyNumber=0, likeNumber=27, createdTime=2019-08-28, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0f9158513f6, moduleTitle=《2018年国际肝移植协会意见：非酒精性脂肪性肝炎的管理和治疗》摘译, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0f9158513f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810116, encodeId=245418101160f, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Diabetes Obes Metab：双醋瑞因在减少2型糖尿病合并非酒精性脂肪性肝病患者肝脂肪变性和纤维化的疗效, objectType=article, longId=159508, objectId=7d6f15950816, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d6f15950816, replyNumber=0, likeNumber=72, createdTime=2019-02-10, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d6f15950816, moduleTitle=Diabetes Obes Metab：双醋瑞因在减少2型糖尿病合并非酒精性脂肪性肝病患者肝脂肪变性和纤维化的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d6f15950816)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810130, encodeId=33c5181013067, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=GENFIT宣布DSMB的积极建议，将继续进行Elafibranor治疗非酒精性脂肪性肝炎的3期临床研究, objectType=article, longId=166113, objectId=36251661133d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36251661133d, replyNumber=0, likeNumber=62, createdTime=2019-12-12, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36251661133d, moduleTitle=GENFIT宣布DSMB的积极建议，将继续进行Elafibranor治疗非酒精性脂肪性肝炎的3期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36251661133d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810103, encodeId=00b9181010386, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J Hepatology：生活方式干预对非酒精性脂肪性肝病非肥胖患者有好处, objectType=article, longId=154408, objectId=39ce1544086a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39ce1544086a, replyNumber=0, likeNumber=94, createdTime=2019-06-17, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39ce1544086a, moduleTitle=J Hepatology：生活方式干预对非酒精性脂肪性肝病非肥胖患者有好处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39ce1544086a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810096, encodeId=e46e181009633, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=AP&T：无麸质饮食的乳糜泻患者会增加患非酒精性脂肪性肝病的风险, objectType=article, longId=147793, objectId=de6614e793ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de6614e793ad, replyNumber=0, likeNumber=84, createdTime=2018-12-31, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de6614e793ad, moduleTitle=AP&T：无麸质饮食的乳糜泻患者会增加患非酒精性脂肪性肝病的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de6614e793ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810095, encodeId=1131181009572, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=PLos One：RA患者MTX治疗期间肝活检中的非酒精性脂肪性肝炎样类型, objectType=article, longId=147397, objectId=35f714e397ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35f714e397ba, replyNumber=0, likeNumber=0, createdTime=2018-10-03, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35f714e397ba, moduleTitle=PLos One：RA患者MTX治疗期间肝活检中的非酒精性脂肪性肝炎样类型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35f714e397ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810119, encodeId=a49e18101196c, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Curr Pharm Des：他汀类药物在非酒精性脂肪性肝病治疗中的作用, objectType=article, longId=160565, objectId=a4b716056511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4b716056511, replyNumber=0, likeNumber=76, createdTime=2019-03-28, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4b716056511, moduleTitle=Curr Pharm Des：他汀类药物在非酒精性脂肪性肝病治疗中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4b716056511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810098, encodeId=cef01810098a7, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Viking非酒精性脂肪性肝炎候选药VK2809二期临床试验成功, objectType=article, longId=149201, objectId=412214920109, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=412214920109, replyNumber=0, likeNumber=72, createdTime=2019-05-23, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=412214920109, moduleTitle=Viking非酒精性脂肪性肝炎候选药VK2809二期临床试验成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=412214920109)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810102, encodeId=6b56181010210, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=诺华和辉瑞联合开发非酒精性脂肪性肝炎NASH药物, objectType=article, longId=152461, objectId=72d315246142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72d315246142, replyNumber=0, likeNumber=91, createdTime=2019-06-26, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72d315246142, moduleTitle=诺华和辉瑞联合开发非酒精性脂肪性肝炎NASH药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72d315246142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810108, encodeId=4b2f181010886, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J Hepatology：健康生活方式可以改善非酒精性脂肪性肝病患者的病情, objectType=article, longId=156255, objectId=e7ce15625572, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7ce15625572, replyNumber=0, likeNumber=58, createdTime=2019-08-01, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7ce15625572, moduleTitle=J Hepatology：健康生活方式可以改善非酒精性脂肪性肝病患者的病情, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7ce15625572)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810104, encodeId=bfad18101042a, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=HighTide制药的非酒精性脂肪性肝炎（NASH）疗法HTD1801已获得美国FDA批准, objectType=article, longId=154608, objectId=aa811546081e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa811546081e, replyNumber=0, likeNumber=84, createdTime=2019-10-18, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa811546081e, moduleTitle=HighTide制药的非酒精性脂肪性肝炎（NASH）疗法HTD1801已获得美国FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa811546081e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810100, encodeId=529e18101000c, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J Gastroenterology：骨骼肌质量与脂肪的比值增加可以预测非酒精性脂肪性肝病患者转氨酶的下降, objectType=article, longId=150291, objectId=759e150291ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=759e150291ae, replyNumber=0, likeNumber=70, createdTime=2019-05-17, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=759e150291ae, moduleTitle=J Gastroenterology：骨骼肌质量与脂肪的比值增加可以预测非酒精性脂肪性肝病患者转氨酶的下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=759e150291ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

脂肪性

2020-05-29

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Intercept公司的奥贝胆酸即将成为第一个获批的非酒精性脂肪性肝炎（NASH）药物

2019-11-23

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Hepatology：维生素E能改善非酒精性脂肪性肝炎和晚期肝硬化患者的免移植生存率和失代偿发生率

2019-06-04

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Clinica Chimica Acta：非酒精性脂肪性肝炎患者血清脂蛋白中缩醛磷脂的组成及其对氧化作用的敏感性

2019-09-11

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

AJG：吸烟与非酒精性脂肪性肝病发生风险之间的关系

2020-03-08

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Terns宣布其血管粘附蛋白-1抑制剂TERN-201治疗非酒精性脂肪性肝炎的I期临床中期阳性结果

2020-07-11

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Hepatology：丁酸钠可以通过上调肝脏GLP-1R表达减少高脂饮食诱导的非酒精性脂肪性肝炎

2019-02-23

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Clin Trans Gastroenterology：血清可溶性受体AGE（sRAGE）水平与不健康的生活方式和非酒精性脂肪性肝病相关

2020-04-15

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Gastroenterology：Simtuzumab对非酒精性脂肪性肝炎引起的桥接纤维化或代偿性肝硬化治疗无效

2019-09-04

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

《2018年国际肝移植协会意见：非酒精性脂肪性肝炎的管理和治疗》摘译

2019-08-28

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Diabetes Obes Metab：双醋瑞因在减少2型糖尿病合并非酒精性脂肪性肝病患者肝脂肪变性和纤维化的疗效

2019-02-10

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

GENFIT宣布DSMB的积极建议，将继续进行Elafibranor治疗非酒精性脂肪性肝炎的3期临床研究

2019-12-12

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J Hepatology：生活方式干预对非酒精性脂肪性肝病非肥胖患者有好处

2019-06-17

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

AP&T：无麸质饮食的乳糜泻患者会增加患非酒精性脂肪性肝病的风险

2018-12-31

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

PLos One：RA患者MTX治疗期间肝活检中的非酒精性脂肪性肝炎样类型

2018-10-03

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Curr Pharm Des：他汀类药物在非酒精性脂肪性肝病治疗中的作用

2019-03-28

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Viking非酒精性脂肪性肝炎候选药VK2809二期临床试验成功

2019-05-23

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

诺华和辉瑞联合开发非酒精性脂肪性肝炎NASH药物

2019-06-26

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J Hepatology：健康生活方式可以改善非酒精性脂肪性肝病患者的病情

2019-08-01

智慧医人 (审核中...)

前往app查看评论内容

#脂肪性#

HighTide制药的非酒精性脂肪性肝炎（NASH）疗法HTD1801已获得美国FDA批准

2019-10-18

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J Gastroenterology：骨骼肌质量与脂肪的比值增加可以预测非酒精性脂肪性肝病患者转氨酶的下降

2019-05-17

科室
- - 订阅+
  - 更多科室
工具
服务